Vyome Holdings Inc (HIND)

09:05 AM

Vyome Holdings Announces Results of Annual Shareholder Meeting - The Joplin Globe

09:05 AM

Nov 02, 2025

Comparing Anzu Special Acquisition Corp I (NASDAQ:ANZUW) & Vyome (NASDAQ:HIND) - Defense World

Nov 02, 2025

Oct 31, 2025

Vyome Holdings, Inc.Common Stock (Nasdaq:HIND) Stock Quote - FinancialContent

Oct 31, 2025

Oct 30, 2025

Vyome Holdings Elects Directors at Annual Meeting - TipRanks

Oct 30, 2025

Oct 27, 2025

Head-To-Head Contrast: Vyome (NASDAQ:HIND) & TranS1 (OTCMKTS:BAXSQ) - Defense World

Oct 27, 2025

Oct 25, 2025

ReShape Lifesciences : trade; to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate UpdateForm 8-K/A - MarketScreener

Oct 25, 2025

Oct 17, 2025

Tincoff John M. Iii Net Worth (2025) - GuruFocus

Oct 17, 2025

Oct 16, 2025

ReShape Lifesciences (OTCMKTS:RSLSD) versus Vyome (NASDAQ:HIND) Financial Survey - Defense World

Oct 16, 2025

Oct 13, 2025

Will Vyome's Topical Gel Be The First FDA-Approved Treatment For Cancer Wounds? - RTTNews

Oct 13, 2025

Oct 12, 2025

Head-To-Head Comparison: Vyome (NASDAQ:HIND) vs. Bioventus (NASDAQ:BVS) - Defense World

Oct 12, 2025

Oct 06, 2025

Head to Head Survey: Vyome (NASDAQ:HIND) versus CapsoVision (NASDAQ:CV) - Defense World

Oct 06, 2025

Oct 04, 2025

Maxim Group Reaffirms “Buy” Rating for Vyome (NASDAQ:HIND) - Defense World

Oct 04, 2025

Oct 03, 2025

Vyome Holdings Acquires AI Startup Oculo, Inc. - TipRanks

Oct 03, 2025

Oct 02, 2025

HIND Analyst Forecasts - Quiver Quantitative

Oct 02, 2025

Sep 30, 2025

Vyome Holdings acquires Oculo Health - Medical Buyer

Sep 30, 2025

Sep 30, 2025

Vyome Holdings Acquires MIT Spinout Oculo Health, Launches AI Psychiatrist Business Unit - Sahyadri Startups

Sep 30, 2025

Sep 29, 2025

Vyome Holdings Acquires MIT AI Spinout Oculo Health - citybiz

Sep 29, 2025

Sep 29, 2025

Vyome acquires AI startup Oculo to develop inflammation-focused digital therapeutics By Investing.com - Investing.com South Africa

Sep 29, 2025

Sep 29, 2025

Vyome acquires AI startup Oculo to develop inflammation-focused digital therapeutics - Investing.com Nigeria

Sep 29, 2025

Sep 29, 2025

Vyome Holdings acquires MIT AI spinout Oculo Health - MarketScreener

Sep 29, 2025

Sep 26, 2025

Vyome shares surge after encouraging preclinical data for eye treatment - MSN

Sep 26, 2025

Sep 17, 2025

BC-Most Active Stocks - upstatetoday.com

Sep 17, 2025

Sep 17, 2025

Why Is BBAI Stock Falling Today? - Stocktwits

Sep 17, 2025

Sep 17, 2025

HIND Stock Rallies 70% Pre-Market Today Find Out Why - Menafn

Sep 17, 2025

Sep 17, 2025

HIND Stock: Growth or Bubble? - StocksToTrade

Sep 17, 2025

Sep 17, 2025

HIND Stock Rallies 70% Pre-Market Today – Find Out Why - Asianet Newsable

Sep 17, 2025

Sep 17, 2025

Vyome Holdings (HIND) Skyrockets Over 50% on Breakthrough Uveitis Treatment News - RagingBull

Sep 17, 2025

Sep 17, 2025

Vyome stock soars after positive preclinical results for eye drug - Investing.com India

Sep 17, 2025

Sep 17, 2025

Vyome stock soars after positive preclinical results for eye drug By Investing.com - Investing.com Nigeria

Sep 17, 2025

Sep 17, 2025

Morning Market Movers: SPRC, HIND, SQFT, FGNX See Big Swings - RTTNews

Sep 17, 2025

Sep 17, 2025

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity - Business Wire

Sep 17, 2025

Sep 10, 2025

Vertiv’s Stock Surge: Will it Last? - StocksToTrade

Sep 10, 2025

Sep 09, 2025

Vyome Holdings Appoints Dr. Richard Fahrner as CTO and Dr. Tamara Agajanov, MD, as SVP – Clinical Development - citybiz

Sep 09, 2025

Sep 09, 2025

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies - PharmiWeb.com

Sep 09, 2025

Sep 09, 2025

Vyome Holdings strengthens leadership team with industry veterans as it plans pivotal trial studies - MarketScreener

Sep 09, 2025

Sep 08, 2025

Vyome Holdings Completes Merger with Vyome Therapeutics - MSN

Sep 08, 2025

Sep 05, 2025

Vyome’s VT-1953 shows significant reduction in cancer wound odor By Investing.com - Investing.com Nigeria

Sep 05, 2025

Sep 05, 2025

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity - biospace.com

Sep 05, 2025

Sep 05, 2025

Vyome Therapeutics2025 Latest Shareholding - Tracxn

Sep 05, 2025

Sep 04, 2025

Vyome’s VT-1953 shows significant reduction in cancer wound odor - Investing.com India

Sep 04, 2025

Sep 04, 2025

Vyome Holdings Inc positive interim data from Phase 2 Study of VT-1953 in malignant fungating wounds - MarketScreener

Sep 04, 2025

Sep 02, 2025

Vyome Holdings completes merger with Vyome Therapeutics and files financials By Investing.com - Investing.com Canada

Sep 02, 2025

Sep 02, 2025

Vyome Holdings completes merger with Vyome Therapeutics and files financials - Investing.com

Sep 02, 2025

Aug 26, 2025

Vyome Holdings, Embryyo Technologies Partner on AI Medtech - Medical Product Outsourcing

Aug 26, 2025

Aug 24, 2025

Vyome Holdings, Inc. (HIND) Company Profile & Facts - Yahoo

Aug 24, 2025